Final-Program-ATS-2023-AP.vp

TUESDAY • MAY 23

251

P13 Predicting Intensive Care Unit Admissions in Patients With Alcohol Withdrawal Using Electronic Health Record Data/ D. To, Madison, WI P14 Clinical Institute Withdrawal Assessment (CIWA) Scores and Benzodiazepine Dosing for Identifying Severe Alcohol Withdrawal/ D. To, Madison, WI P15 Enrichment of Mortality Events in Patients With Substance Misuse for Critical Care Research Utilizing Local, State, and National Data Sources/ P. Gupta, Chicago, IL P16 Practice Patterns and Outcomes Associated With the Intravenous Sodium Bicarbonate Shortage Among Critically Ill Patients With Acidosis/ P. Murphy, Boston, MA P17 Breaking the Myths About Phenobarbital for Alcohol Withdrawal: Retrospective Study/ K. Golubykh, Harrisburg, PA P18 Making the Cut During Codes: Time to Performance of Critical Actions by Rapid Medical Response Team Members During Simulated Cardiac Arrest/ K. Auge, Chicago, IL P19 Ketamine Infusion Compared to Dexmedetomidine for ICU Sedation: A Retrospective Study/ B. Asllanaj, Las Vegas, NV

CLINICAL THEMATIC POSTER SESSION

C46

STUDIES IN CARDIAC ARREST, ICU PHARMACY, AND ALCOHOL WITHDRAWAL

9:00 a.m. - 4:15 p.m.

Walter E. Washington Convention Center Area A, Hall C (Lower Level)

Viewing: Posters will be on display for entire session

11:30-1:15

Discussion: 11:30-12:15 authors will be present for individual discussion 12:15-1:15 authors will be present for discussionwith assigned facilitators. Internal Targeted Hypothermia Versus Normothermia After Cardiac Arrest: Systematic Review and Meta-analysis, an Update/ Y.B. Moreno, Fort Lauderdale, FL Outcomes of Outside In-hospital Cardiac Arrest Adult Patients After Post-resuscitation ECMO at a Referral Center/ J. Buchner, Falls Church, VA Cardiac Output and Improved Patient Outcomes/ J. Sahatjian, Deerfield, IL Novel Approach to Cardiac Arrest Prevention/ A. Korus, New Haven, CT The Use of Ibutilide for Cardioversion of Atrial Fibrillation in Medical and Surgical Intensive Care Patients/ A.T. Phan, Colton, CA Administration of Blood Products During In-hospital Cardiac Arrest Is Not Associated With Improved Survival/ A.A. Gupta, San Diego, CA Cardiac Arrest Outcomes With or Without COVID-19 Infection in a Population of Veterans / K. Phillips, San Antonio, TX Epidemiology, Risk Factors and Outcomes Associated With In-hospital Reflex-mediated Cardiac Arrest/ T. Pham, San Diego, CA Prognostication After Cardiac Arrest: Why Aren’t We Using the Tools We Already Have?/ M. Jefkins, Kingston, Canada P10 Prediction of Drug Capturing by Lipid Emulsions In Vivo for the Treatment of a Drug Overdose/ H. Sun, Nanjing, China P11 Modified Minnesota Detoxification Scale (mMINDS) Protocol Assessment for Treatment of Patients With Severe Alcohol Withdrawal/ S. Khan, Morgantown, WV P12 Effect of Haloperidol on Mortality, Number of Adverse Effects and Length of Stay Among Patients in the Intensive Care Unit: An Updated Systematic Review and Meta-analysis/ C.B. Marcano, Fort Lauderdale, FL P1 P2 P3 P4 P5 P6 P7 P8 P9

CLINICAL THEMATIC POSTER SESSION

C47

ORGAN FAILURES AND SHOCK: CASE REPORTS

9:00 a.m. - 4:15 p.m.

Walter E. Washington Convention Center Area A, Hall C (Lower Level)

Viewing: Posters will be on display for entire session

11:30-1:15

Discussion: 11:30-12:15 authors will be present for individual discussion 12:15-1:15 authors will be present for discussionwith assigned facilitators. P21 What a Shock: An Unusual Presentation of Obstructive Shock/ A. Martinez Nunez, Aventura, FL P22 Refractory Undifferentiated Shock. Is Methylene Blue Our Last Option?/ C. Arevalo, Rochester, NY P23 An Atypical Presentation of Legionella Pneumonia With Obstructive Shock/ R.P. Rane, Johnstown, PA P24 Are We Missing the Source: A Case of Premature Closure in Septic Shock/ K. Rai, Aurora, CO P25 Fatal Predisposition for Toxic Shock Syndrome in Klippel-Trenaunay-Weber Syndrome/ J.T. Tamizharasu, Sacramento, CA

ATS 2023 • Washington, DC